There's a very simple reason why EDTA chelation therapy is not more
widely accepted for treatment of atherosclerotic coronary artery disease.
Multiple randomized clinical trials have failed to show a benefit
greater than placebo in either symptoms or arterial occlusion as
measured by angiography.
It's that simple.
--
Orac |"A statement of fact cannot be insolent."
|
|"If you cannot listen to the answers, why do you
| inconvenience me with questions?"